PC54840
|
(±)11(12)-EET MaxSpec® Standard |
274260-05-8 |
Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards|MaxSpec®||Product Type|Biochemicals|Lipids|Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways |
PC54841
|
(±)14(15)-DiHET MaxSpec® Standard |
108457-42-7 |
Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards|MaxSpec®||Product Type|Biochemicals|Lipids|Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways |
PC54839
|
(±)8(9)-EET MaxSpec® Standard |
17297-99-3 |
Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards|MaxSpec®||Product Type|Biochemicals|Lipids|Hydroxy/Hydroperoxy/Epoxy/Oxo Eicosanoids||Product Type|Biochemicals|Receptor Pharmacology|Agonists||Product Type|Biochemicals|Small Molecule Inhibitors|TNF-α/NF-κB Signaling||Research Area|Cardiovascular System|Kidney & Renal Disease||Research Area|Cardiovascular System|Vasculature|Vasoconstriction||Research Area|Cell Biology|Cell Signaling|NF-κB Signaling||Research Area|Endocrinology & Metabolism|Hormones & Receptors|PPARs||Research Area|Epigenetics, Transcription, & Translation|Transcription Factors||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway||Research Area|Lipid Biochemistry|Cytochrome P450 Pathways |
PC54842
|
FABP3 (human, recombinant) |
128960-77-0 |
Application|Western Blot||Product Type|Proteins||Research Area|Cardiovascular System|Cardiovascular Diseases|Myocardial Infarction||Research Area|Cardiovascular System|Heart |
PC70839
|
谷胱甘肽杂质06对照品 |
17297-99-3 |
|
PC70840
|
谷胱甘肽杂质07对照品 |
274260-05-8 |
|
PC70841
|
谷胱甘肽杂质08对照品 |
108457-42-7 |
|
PC70842
|
谷胱甘肽杂质09对照品 |
128960-77-0 |
|